[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Polycythemia Vera Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

December 2020 | 99 pages | ID: PBA166A0D11EEN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Polycythemia Vera Drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Polycythemia Vera Drug market segmented into
  • Dasatinib
  • Idelalisib
  • Givinostat
  • M-009
  • Others
Based on the end-use, the global Polycythemia Vera Drug market classified into
  • Clinic
  • Hospital
  • Others
Based on geography, the global Polycythemia Vera Drug market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • ANP Technologies, Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Galena Biopharma, Inc.
  • Gilead Sciences, Inc.
  • Italfarmaco S.p.A.
  • Karus Therapeutics Limited
  • miRagen Therapeutics, Inc.
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG
  • PharmaEssentia Corporation
  • Teva Pharmaceutical Industries Ltd.
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL POLYCYTHEMIA VERA DRUG INDUSTRY

2.1 Summary about Polycythemia Vera Drug Industry
2.2 Polycythemia Vera Drug Market Trends
  2.2.1 Polycythemia Vera Drug Production & Consumption Trends
  2.2.2 Polycythemia Vera Drug Demand Structure Trends
2.3 Polycythemia Vera Drug Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Dasatinib
  4.2.2 Idelalisib
  4.2.3 Givinostat
  4.2.4 M-009
  4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Clinic
  4.3.2 Hospital
  4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Dasatinib
  5.2.2 Idelalisib
  5.2.3 Givinostat
  5.2.4 M-009
  5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Clinic
  5.3.2 Hospital
  5.3.3 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Dasatinib
  6.2.2 Idelalisib
  6.2.3 Givinostat
  6.2.4 M-009
  6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Clinic
  6.3.2 Hospital
  6.3.3 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Dasatinib
  7.2.2 Idelalisib
  7.2.3 Givinostat
  7.2.4 M-009
  7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Clinic
  7.3.2 Hospital
  7.3.3 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Dasatinib
  8.2.2 Idelalisib
  8.2.3 Givinostat
  8.2.4 M-009
  8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Clinic
  8.3.2 Hospital
  8.3.3 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Dasatinib
  9.2.2 Idelalisib
  9.2.3 Givinostat
  9.2.4 M-009
  9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Clinic
  9.3.2 Hospital
  9.3.3 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 ANP Technologies, Inc.
  10.1.2 Bristol-Myers Squibb Company
  10.1.3 F. Hoffmann-La Roche Ltd.
  10.1.4 Galena Biopharma, Inc.
  10.1.5 Gilead Sciences, Inc.
  10.1.6 Italfarmaco S.p.A.
  10.1.7 Karus Therapeutics Limited
  10.1.8 miRagen Therapeutics, Inc.
  10.1.9 Nerviano Medical Sciences S.r.l.
  10.1.10 Novartis AG
  10.1.11 PharmaEssentia Corporation
  10.1.12 Teva Pharmaceutical Industries Ltd.
10.2 Polycythemia Vera Drug Sales Date of Major Players (2017-2020e)
  10.2.1 ANP Technologies, Inc.
  10.2.2 Bristol-Myers Squibb Company
  10.2.3 F. Hoffmann-La Roche Ltd.
  10.2.4 Galena Biopharma, Inc.
  10.2.5 Gilead Sciences, Inc.
  10.2.6 Italfarmaco S.p.A.
  10.2.7 Karus Therapeutics Limited
  10.2.8 miRagen Therapeutics, Inc.
  10.2.9 Nerviano Medical Sciences S.r.l.
  10.2.10 Novartis AG
  10.2.11 PharmaEssentia Corporation
  10.2.12 Teva Pharmaceutical Industries Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

LIST OF TABLES
Table Polycythemia Vera Drug Product Type Overview
Table Polycythemia Vera Drug Product Type Market Share List
Table Polycythemia Vera Drug Product Type of Major Players
Table Brief Introduction of ANP Technologies, Inc.
Table Brief Introduction of Bristol-Myers Squibb Company
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of Galena Biopharma, Inc.
Table Brief Introduction of Gilead Sciences, Inc.
Table Brief Introduction of Italfarmaco S.p.A.
Table Brief Introduction of Karus Therapeutics Limited
Table Brief Introduction of miRagen Therapeutics, Inc.
Table Brief Introduction of Nerviano Medical Sciences S.r.l.
Table Brief Introduction of Novartis AG
Table Brief Introduction of PharmaEssentia Corporation
Table Brief Introduction of Teva Pharmaceutical Industries Ltd.
Table Products & Services of ANP Technologies, Inc.
Table Products & Services of Bristol-Myers Squibb Company
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of Galena Biopharma, Inc.
Table Products & Services of Gilead Sciences, Inc.
Table Products & Services of Italfarmaco S.p.A.
Table Products & Services of Karus Therapeutics Limited
Table Products & Services of miRagen Therapeutics, Inc.
Table Products & Services of Nerviano Medical Sciences S.r.l.
Table Products & Services of Novartis AG
Table Products & Services of PharmaEssentia Corporation
Table Products & Services of Teva Pharmaceutical Industries Ltd.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Polycythemia Vera Drug Market Forecast (Million USD) by Region 2021f-2026f
Table Global Polycythemia Vera Drug Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Polycythemia Vera Drug Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Polycythemia Vera Drug Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Polycythemia Vera Drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Polycythemia Vera Drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Polycythemia Vera Drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Polycythemia Vera Drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Polycythemia Vera Drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Polycythemia Vera Drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Polycythemia Vera Drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dasatinib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Idelalisib Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Givinostat Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure M-009 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of ANP Technologies, Inc. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Bristol-Myers Squibb Company 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of F. Hoffmann-La Roche Ltd. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Galena Biopharma, Inc. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Gilead Sciences, Inc. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Italfarmaco S.p.A. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Karus Therapeutics Limited 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of miRagen Therapeutics, Inc. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Nerviano Medical Sciences S.r.l. 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of PharmaEssentia Corporation 2017-2020e
Figure Polycythemia Vera Drug Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd. 2017-2020e


More Publications